Gensaic, Inc.

Lexington, MA Doing business as M13 Therapeutics

UEI
SLYECZ48LB75
CAGE
956D9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Other Than One of the Proceeding
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
56 Meriam St, Lexington, MA 02420, USA
Website
gensaic.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Bioengineering of phage-derived particles as a discovery platform for muscle gene therapy R43TR004744 National Center for Advancing Translational Sciences (NIH) $334,571

Quick answers

Is Gensaic, Inc. registered in SAM.gov?

Yes. Gensaic, Inc.'s SAM.gov registration is active through June 5, 2027.

What is Gensaic, Inc.'s most recent federal award?

Gensaic, Inc.'s most recent federal grant award is Bioengineering of phage-derived particles as a discovery platform for muscle gene therapy (R43TR004744), from National Center for Advancing Translational Sciences (NIH), on September 1, 2023.

On GovTribe

See Gensaic, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login